Heron Therapeutics, Inc. (NASDAQ: HRTX) announced the pricing of an underwritten public offering of $150 million of shares of its ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE